Author

E. D. Hottz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. C. Ferreira· 2 shared C. Q. Sacramento· 2 shared C. R. R. Pao· 2 shared C. S. de Freitas· 2 shared D. C. Bou-Habib· 2 shared F. A. Bozza· 2 shared J. R. Temerozo· 2 shared L. Teixeira· 2 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. C. Ferreira

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators

S. S. Gomes Dias, V. S. Cardoso, A. C. Ferreira, C. Q. Sacramento, N. Fintelman-Rodrigues, J. R. Temerozo, L. Teixeira, E. A. Barreto, M. Mattos, C. S. de Freitas, I. Azevedo-Quintanilha, P. P. A. Manso, E. D. Hottz, C. R. R. Pao, D. C. Bou-Habib, , P. T. Bozza

This study shows that lipid droplets support SARS-CoV-2 replication and inflammatory mediator production, with DGAT-1 inhibition reducing viral replication and inflammation.

bioRxiv · Aug 22, 2020 · PreprintImmunology

VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells.

J. R. Temerozo, C. Q. Sacramento, N. Fintelman-Rodrigues, C. R. R. Pao, C. S. de Freitas, S. d. S. G. Dias, A. C. Ferreira, M. Mattos, V. C. Soares, L. Teixeira, I. G. de Azevedo-Quintanilha, E. D. Hottz, P. Kurtz, F. A. Bozza, P. T. Bozza, , D. C. Bou-Habib

The paper shows elevated VIP plasma levels in severe COVID-19 patients correlate with survival and protective effects against SARS-CoV-2 in vitro.

bioRxiv · Jul 25, 2020Immunology